Related Experiment Video
Updated: Jun 26, 2026
Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
Neonatal/newborn haemoglobinopathy screening in Europe and Africa
1Department of Haematology, St Mary's Hospital, London, UK. b.bain@ic.ac.uk
Insights
Neonatal screening for haemoglobinopathy, including sickle cell disease, is expanding globally. Early detection improves infant care through education and infection prevention strategies.
Area of Science:
- Medical Science
- Public Health
- Genetics
Background:
- Changing immigration patterns increase the number of neonates at risk for sickle cell disease in Europe.
- Haemoglobinopathy screening programs vary, with some standalone and others integrated into metabolic disorder screening.
Purpose of the Study:
- To outline the growing implementation of neonatal haemoglobinopathy screening.
- To highlight the benefits of early detection for managing sickle cell disease.
Main Methods:
- Review of current neonatal screening practices for haemoglobinopathies.
- Analysis of program integration and standalone approaches.
Main Results:
- Increasing adoption of neonatal haemoglobinopathy screening in European countries.
- Gradual introduction of screening programs in African nations despite challenges.
Conclusions:
- Neonatal haemoglobinopathy screening is crucial for early intervention in sickle cell disease.
- Screening programs are expanding despite logistic and economic constraints.
Abstract:
Neonatal/newborn haemoglobinopathy screening is being performed in an increasing number of European countries since changing patterns of immigration have led to significant numbers of neonates at risk of sickle cell disease. The purpose of screening is to improve management of sickle cell disease through early parental education and the institution of prophylaxis against infection. Some haemoglobinopathy screening programmes are stand-alone, while others are integrated into a neonatal screening programme for metabolic disorders. Despite the logistic problems and economic constraints, neonatal haemoglobinopathy screening is also being gradually introduced in a number of African countries.
